Atsushi Kurabayashi

Dr. Atsushi Kurabayashi

orcid

Research Focus & Metrics

Academic Career Length

18Years (2009-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 August 2015 in BMC Urology
Verified
Journal Article
Open access
PDF file
HFHideo Fukuhara
Hideo Fukuhara
KIKeiji Inoue
Keiji Inoue
AKAtsushi Kurabayashi
Atsushi Kurabayashi
MFMutsuo Furihata
Mutsuo Furihata
TSTaro Shuin
Taro Shuin
The aim of this study was to investigate whether we could detect positive surgical margins during open and laparoscopic radical prostatectomy by 5-aminolevulinic acid (ALA) photodynamic diagnosis (PDD) and mapping of red fluorescence in human prostate cancer cells. All 52 patients were diagnosed with prostate cancer by biopsy. They had a positive core in the apex or highly suspicious positive margins. Open and laparoscopic radical prostatectomy was performed in 18 and 34 cases, respectively. One gram of ALA solution was given intraoperatively, orally through a stomach tube. An endoscopic PDD system, including a D-Light C, CCU Tricam SLII/3CCD CH Tricam-P PDD, and HOPKINS II Straight Forward Telescope 0°, was used. The D-Light C light source was equipped with a band-pass filter. The CCU Tricam SLII/3CCD CHTricam-P PDD video camera system was equipped with a long-pass filter. The laparoscopy optic component was equipped with a yellow long-pass filter. One of the 52 patients had a red-fluorescent-positive margin of the excised whole prostate and the positive surgical margin was histologically confirmed. In the section of excised prostate, we obtained 141 biopsied samples. The sensitivity and specificity were 75.0 % and 87.3 %, respectively. Intraoperative ALA-PDD is feasible. However, heat degeneration and length of positive surgical margin have crucial influences on red fluorescence. In future, a randomized clinical trial should be carried out.

21 January 2010 in Pathology International
Verified
Journal Article
Closed access
PDF file
AKAtsushi Kurabayashi
Atsushi Kurabayashi
MIMitsuko Iguchi
Mitsuko Iguchi
MMManabu Matsumoto
Manabu Matsumoto
MHMakoto Hiroi
Makoto Hiroi
MKMotohiko Kume
Motohiko Kume
MFMutsuo Furihata
Mutsuo Furihata

24 March 2020 in International Journal of Surgical Pathology
Verified
Journal Article
Closed access
PDF file
WIWaka Iwashita
Waka Iwashita
AKAtsushi Kurabayashi
Atsushi Kurabayashi
CTChiharu Tanaka
Chiharu Tanaka
SNSeiji Naganuma
Seiji Naganuma
TKTakanori Kawamura
Takanori Kawamura
MFMutsuo Furihata
Mutsuo Furihata
Superficial angiomyxoma is a rare, benign, multilobulated cutaneous tumor composed of stellate and spindle cells, a prominent myxoid matrix, and numerous blood vessels. Superficial angiomyxoma may be indistinguishable from cutaneous lesions of the Carney complex, although superficial angiomyxoma can occur independently of the complex. In this article, we present the case of a 39-year-old Japanese woman with a 40 × 30 mm, focally ulcerated, polypoid superficial angiomyxoma on the left nipple without any evidence of Carney complex. The development of superficial angiomyxoma on the nipples in a patient without the Carney complex is extremely rare. Indeed, only 3 cases of superficial angiomyxoma arising on the nipple have been reported to date, and this is the first such report in Japan. In such cases, the majority of superficial angiomyxoma of the nipples develop in premenopausal women. The possibility of superficial angiomyxoma should be considered for all polypoid nipple lesion, particularly in premenopausal women, and complete excision with follow-up observation should be performed.

22 June 2024 in Cancers
Verified
Journal Article
Open access
PDF file
AKAtsushi Kurabayashi
Atsushi Kurabayashi
HFHideo Fukuhara
Hideo Fukuhara
KFKaoru Furihata
Kaoru Furihata
WIWaka Iwashita
Waka Iwashita
MFMutsuo Furihata
Mutsuo Furihata
KIKeiji Inoue
Keiji Inoue
Bladder cancer (BC) possesses distinct molecular profiles that influence progression depending on its biological nature and delivered treatment intensity. Muscle-invasive BC (MIBC) and non-MIBC (NMIBC) demonstrate great intrinsic heterogeneity regarding different prognoses, survival, progression, and treatment outcomes. Transurethral resection of bladder tumor (TURBT) is the standard of care in treating NMIBC and serves both diagnostic and therapeutic purposes despite the prevalent recurrence and progression among many patients. In particular, flat urothelial carcinoma in situ and urothelial carcinoma with lamina propria invasion are the major precursors of MIBC. A new-generation photosensitizer, 5-Aminolevulinic acid (5-ALA), demonstrates high tumor specificity by illuminating the tumor lesion with a specific wavelength of light to produce fluorescence and has been studied for photodynamic diagnosis to detect precise tumor areas by TURBT. Additionally, it has been applied for treatment by producing its cytotoxic reactive oxygen species, as well as screening for urological carcinomas by excreting porphyrin in the blood and urine. Moreover, 5-ALA may contribute to screening before and after TURBT in NMIBC. Here, we summarize the updated evidence and ongoing research on photodynamic technology for NMIBC, providing insight into the potential for improving patient outcomes.

26 September 2009 in Medical Molecular Morphology
Verified
Journal Article
Closed access
PDF file
YOYuji Ohtsuki
Yuji Ohtsuki
MKMasashi Kimura
Masashi Kimura
SMSatoshi Murao
Satoshi Murao
YOYuhei Okada
Yuhei Okada
YTYuki Teratani
Yuki Teratani
MFMutsuo Furihata
Mutsuo Furihata

27 April 2022 in Plasma
Verified
Journal Article
Open access
PDF file
HFHideo Fukuhara
Hideo Fukuhara
ESEndre Szili
Endre Szili
JOJun-Seok Oh
Jun-Seok Oh
KCKawada Chiaki
Kawada Chiaki
SYShinkuro Yamamoto
Shinkuro Yamamoto
KIKeiji Inoue
Keiji Inoue
Current methods used to treat non-muscle invasive bladder cancer are inadequate due to a high recurrence rate after surgery and the occurrence of adverse events such as interstitial pneumonia following intravesical instillation therapy. Low-temperature plasma is a new form of physical therapy that provides a rich source of reactive oxygen species (ROS). Oxidative solutions, created by pre-treatment of aqueous media with plasma before application to target cells, lead to the destruction of cancer cells through oxidative stress pathways. This study focuses on the effects of plasma-activated media (PAM) in bladder cancer cells. PAM treatment increases oxidative stress that leads to cell cycle arrest and concomitantly depolarises the mitochondrial membrane leading to increased mitochondrial ROS production. Cell cycle arrest and increased mitochondrial ROS production led to an increase in caspase 3/cytochrome c activity, which might explain the induction of apoptosis in bladder cancer cells in vitro and in a bladder cancer tumour in vivo. These observations highlight the potential of plasma activated solutions as a new adjuvant therapy in the clinical treatment of bladder cancer.